W.O. Böcher - Concepedia

Author

W.O. Böcher

Johannes Gutenberg University Mainz

Also Known As

W Böcher, W O Bocher, W O BÖCHER, W O Böcher, W. Böcher, W. O. Böcher, W.O. Bocher, W.O. Böcher, WO Böcher

Publications

481

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz Hôpital Beaujon Boehringer Ingelheim (Germany)Heidelberg University Boehringer Ingelheim (United States)

About

W.O. Böcher is an author at Johannes Gutenberg University Mainz specializing in viral hepatitis, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	134
2	Hepatology	3	3	134
3	Viral Hepatitis	3	3	134
4	Immunology	2	2	68
5	Viral Immunity	1	1	66

W.O. Böcher

Publications

451

Citations

H-Index

Page 1

	Year	Citations
Autoreactive Cd4+ Lkm–Specific and Anticlonotypic T–Cell Responses in Lkm–1 Antibody–Positive Autoimmune Hepatitis H Löhr, JF Schlaak, Ansgar W. Lohse, Hepatology	1996	98
Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection S Tavakoli, Ingmar Mederacke, Sabine Herzog‐Hauff, Clinical & Experimental Immunology	2007	78
Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response <i>in vitro</i> in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection W.O. Böcher, Sabine Herzog‐Hauff, W. Herr, Clinical & Experimental Immunology	1996	67
101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2 Stefan Zeuzem, Vincent Soriano, Tarik Asselah, Journal of Hepatology Viral PersistenceHepatology+/- RibavirinViral HepatitisAntiviral Therapy	2012	66
Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12 H Löhr, Sabine Pingel, W.O. Böcher, Clinical & Experimental Immunology	2002	47
60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION Mark Sulkowski, E. Ceasu, Tarik Asselah, Journal of Hepatology Hcv InfectionHepatologyHepatitis CViral PersistenceViral Hepatitis	2011	38
66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R Mark Sulkowski, Marc Bourlière, J.‐P. Bronowicki, Journal of Hepatology Viral PersistenceHepatologyViral HepatitisImmunologyAntiviral Therapy	2011	30
Hepatitis B surface antigen presentation and HLA-DRB1*– lessons from twins and peptide binding studies Anke Krüger, Petra Adams, Juergen Hammer, Clinical & Experimental Immunology	2005	27

Page 1